ID   HS105_HUMAN             Reviewed;         858 AA.
AC   Q92598; B4DYH1; O95739; Q5TBM6; Q5TBM7; Q5TBM8; Q9UPC4;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   07-APR-2021, entry version 213.
DE   RecName: Full=Heat shock protein 105 kDa;
DE   AltName: Full=Antigen NY-CO-25;
DE   AltName: Full=Heat shock 110 kDa protein;
GN   Name=HSPH1; Synonyms=HSP105, HSP110, KIAA0201;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=9931472; DOI=10.1016/s0167-4781(98)00254-1;
RA   Ishihara K., Yasuda K., Hatayama T.;
RT   "Molecular cloning, expression and localization of human 105 kDa heat shock
RT   protein, hsp105.";
RL   Biochim. Biophys. Acta 1444:138-142(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA).
RC   TISSUE=Colon carcinoma;
RX   PubMed=9610721;
RX   DOI=10.1002/(sici)1097-0215(19980529)76:5<652::aid-ijc7>3.0.co;2-p;
RA   Scanlan M.J., Chen Y.-T., Williamson B., Gure A.O., Stockert E.,
RA   Gordan J.D., Tuereci O., Sahin U., Pfreundschuh M., Old L.J.;
RT   "Characterization of human colon cancer antigens recognized by autologous
RT   antibodies.";
RL   Int. J. Cancer 76:652-658(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Bone marrow;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI. The
RT   coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of
RT   cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 332-346 AND 375-388, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [9]
RP   TISSUE SPECIFICITY.
RX   PubMed=10865058; DOI=10.1016/s0006-8993(00)02346-5;
RA   Hylander B.L., Chen X., Graf P.C.F., Subjeck J.R.;
RT   "The distribution and localization of hsp110 in brain.";
RL   Brain Res. 869:49-55(2000).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=16232202; DOI=10.1111/j.1349-7006.2005.00093.x;
RA   Miyazaki M., Nakatsura T., Yokomine K., Senju S., Monji M., Hosaka S.,
RA   Komori H., Yoshitake Y., Motomura Y., Minohara M., Kubo T., Ishihara K.,
RA   Hatayama T., Ogawa M., Nishimura Y.;
RT   "DNA vaccination of HSP105 leads to tumor rejection of colorectal cancer
RT   and melanoma in mice through activation of both CD4 T cells and CD8 T
RT   cells.";
RL   Cancer Sci. 96:695-705(2005).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557; SER-809 AND THR-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-557 AND SER-809, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-809 AND THR-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH HSPA1A AND HSPA1B.
RX   PubMed=24318877; DOI=10.1074/jbc.m113.521997;
RA   Rauch J.N., Gestwicki J.E.;
RT   "Binding of human nucleotide exchange factors to heat shock protein 70
RT   (Hsp70) generates functionally distinct complexes in vitro.";
RL   J. Biol. Chem. 289:1402-1414(2014).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-561, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Acts as a nucleotide-exchange factor (NEF) for chaperone
CC       proteins HSPA1A and HSPA1B, promoting the release of ADP from HSPA1A/B
CC       thereby triggering client/substrate protein release (PubMed:24318877).
CC       Prevents the aggregation of denatured proteins in cells under severe
CC       stress, on which the ATP levels decrease markedly. Inhibits HSPA8/HSC70
CC       ATPase and chaperone activities (By similarity).
CC       {ECO:0000250|UniProtKB:Q60446, ECO:0000250|UniProtKB:Q61699,
CC       ECO:0000269|PubMed:24318877}.
CC   -!- SUBUNIT: Interacts with HSPA8/HSC70 (By similarity). Interacts with
CC       HSPA1A (via NBD) and HSPA1B (via NBD) (PubMed:24318877).
CC       {ECO:0000250|UniProtKB:Q61699, ECO:0000269|PubMed:24318877}.
CC   -!- INTERACTION:
CC       Q92598; Q96BE0; NbExp=3; IntAct=EBI-356829, EBI-9356686;
CC       Q92598; Q62392: Phlda1; Xeno; NbExp=2; IntAct=EBI-356829, EBI-309727;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9931472}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=Alpha;
CC         IsoId=Q92598-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q92598-2; Sequence=VSP_002428;
CC       Name=3;
CC         IsoId=Q92598-3; Sequence=VSP_035428;
CC       Name=4;
CC         IsoId=Q92598-4; Sequence=VSP_054883;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis. Present at lower levels
CC       in most brain regions, except cerebellum. Overexpressed in cancer
CC       cells. {ECO:0000269|PubMed:10865058, ECO:0000269|PubMed:16232202}.
CC   -!- PTM: Phosphorylation on Ser-509 may be important for regulation of the
CC       HSPA8/HSC70 chaperone activity. {ECO:0000250|UniProtKB:Q61699}.
CC   -!- SIMILARITY: Belongs to the heat shock protein 70 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC18044.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=BAA13192.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/HSPH1ID40891ch13q12.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB003333; BAA34779.1; -; mRNA.
DR   EMBL; AB003334; BAA34780.1; -; mRNA.
DR   EMBL; AF039695; AAC18044.1; ALT_INIT; mRNA.
DR   EMBL; D86956; BAA13192.2; ALT_INIT; mRNA.
DR   EMBL; AK302430; BAG63733.1; -; mRNA.
DR   EMBL; AL137142; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471075; EAX08479.1; -; Genomic_DNA.
DR   EMBL; CH471075; EAX08482.1; -; Genomic_DNA.
DR   EMBL; BC037553; AAH37553.1; -; mRNA.
DR   CCDS; CCDS66525.1; -. [Q92598-2]
DR   CCDS; CCDS66526.1; -. [Q92598-4]
DR   CCDS; CCDS9340.1; -. [Q92598-1]
DR   RefSeq; NP_001273432.1; NM_001286503.1. [Q92598-2]
DR   RefSeq; NP_001273433.1; NM_001286504.1. [Q92598-4]
DR   RefSeq; NP_001273434.1; NM_001286505.1.
DR   RefSeq; NP_006635.2; NM_006644.3. [Q92598-1]
DR   PDB; 6GFA; X-ray; 2.00 A; A=1-380.
DR   PDBsum; 6GFA; -.
DR   SMR; Q92598; -.
DR   BioGRID; 116022; 192.
DR   IntAct; Q92598; 76.
DR   MINT; Q92598; -.
DR   STRING; 9606.ENSP00000318687; -.
DR   ChEMBL; CHEMBL3706560; -.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   iPTMnet; Q92598; -.
DR   MetOSite; Q92598; -.
DR   PhosphoSitePlus; Q92598; -.
DR   SwissPalm; Q92598; -.
DR   BioMuta; HSPH1; -.
DR   DMDM; 2495344; -.
DR   REPRODUCTION-2DPAGE; Q92598; -.
DR   CPTAC; CPTAC-526; -.
DR   CPTAC; CPTAC-527; -.
DR   EPD; Q92598; -.
DR   jPOST; Q92598; -.
DR   MassIVE; Q92598; -.
DR   MaxQB; Q92598; -.
DR   PaxDb; Q92598; -.
DR   PeptideAtlas; Q92598; -.
DR   PRIDE; Q92598; -.
DR   ProteomicsDB; 5525; -.
DR   ProteomicsDB; 75344; -. [Q92598-1]
DR   ProteomicsDB; 75345; -. [Q92598-2]
DR   ProteomicsDB; 75346; -. [Q92598-3]
DR   Antibodypedia; 22778; 522 antibodies.
DR   DNASU; 10808; -.
DR   Ensembl; ENST00000320027; ENSP00000318687; ENSG00000120694. [Q92598-1]
DR   Ensembl; ENST00000380405; ENSP00000369768; ENSG00000120694. [Q92598-2]
DR   Ensembl; ENST00000630972; ENSP00000487365; ENSG00000120694. [Q92598-4]
DR   GeneID; 10808; -.
DR   KEGG; hsa:10808; -.
DR   UCSC; uc001utj.5; human. [Q92598-1]
DR   CTD; 10808; -.
DR   DisGeNET; 10808; -.
DR   GeneCards; HSPH1; -.
DR   HGNC; HGNC:16969; HSPH1.
DR   HPA; ENSG00000120694; Tissue enriched (vagina).
DR   MIM; 610703; gene.
DR   neXtProt; NX_Q92598; -.
DR   OpenTargets; ENSG00000120694; -.
DR   PharmGKB; PA134869917; -.
DR   VEuPathDB; HostDB:ENSG00000120694.19; -.
DR   eggNOG; KOG0103; Eukaryota.
DR   GeneTree; ENSGT00940000159635; -.
DR   HOGENOM; CLU_005965_5_1_1; -.
DR   InParanoid; Q92598; -.
DR   OMA; NMLSHAY; -.
DR   OrthoDB; 406172at2759; -.
DR   PhylomeDB; Q92598; -.
DR   TreeFam; TF105043; -.
DR   PathwayCommons; Q92598; -.
DR   Reactome; R-HSA-3000484; Scavenging by Class F Receptors.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   SIGNOR; Q92598; -.
DR   BioGRID-ORCS; 10808; 5 hits in 1001 CRISPR screens.
DR   ChiTaRS; HSPH1; human.
DR   GeneWiki; HSPH1; -.
DR   GenomeRNAi; 10808; -.
DR   Pharos; Q92598; Tbio.
DR   PRO; PR:Q92598; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q92598; protein.
DR   Bgee; ENSG00000120694; Expressed in frontal cortex and 241 other tissues.
DR   ExpressionAtlas; Q92598; baseline and differential.
DR   Genevisible; Q92598; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0071682; C:endocytic vesicle lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:BHF-UCL.
DR   GO; GO:0005874; C:microtubule; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0000774; F:adenyl-nucleotide exchange factor activity; IDA:UniProtKB.
DR   GO; GO:0043014; F:alpha-tubulin binding; IEA:Ensembl.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATPase activity; IEA:InterPro.
DR   GO; GO:0051085; P:chaperone cofactor-dependent protein refolding; IEA:Ensembl.
DR   GO; GO:0045345; P:positive regulation of MHC class I biosynthetic process; TAS:BHF-UCL.
DR   GO; GO:0051135; P:positive regulation of NK T cell activation; TAS:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006986; P:response to unfolded protein; TAS:ProtInc.
DR   CDD; cd11739; HSPH1_NBD; 1.
DR   Gene3D; 1.20.1270.10; -; 1.
DR   Gene3D; 2.60.34.10; -; 1.
DR   InterPro; IPR043129; ATPase_NBD.
DR   InterPro; IPR018181; Heat_shock_70_CS.
DR   InterPro; IPR029048; HSP70_C_sf.
DR   InterPro; IPR029047; HSP70_peptide-bd_sf.
DR   InterPro; IPR013126; Hsp_70_fam.
DR   InterPro; IPR042053; HSPH1_NBD.
DR   Pfam; PF00012; HSP70; 1.
DR   SUPFAM; SSF100920; SSF100920; 1.
DR   SUPFAM; SSF100934; SSF100934; 2.
DR   SUPFAM; SSF53067; SSF53067; 2.
DR   PROSITE; PS01036; HSP70_3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding; Cytoplasm;
KW   Direct protein sequencing; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Stress response.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   CHAIN           2..858
FT                   /note="Heat shock protein 105 kDa"
FT                   /id="PRO_0000078284"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22223895"
FT   MOD_RES         471
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61699"
FT   MOD_RES         509
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61699"
FT   MOD_RES         510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61699"
FT   MOD_RES         557
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692"
FT   MOD_RES         561
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:24275569"
FT   MOD_RES         809
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:19369195, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   MOD_RES         815
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..36
FT                   /note="MSVVGLDVGSQSCYIAVARAGGIETIANEFSDRCTP -> MATAAVLRGPAA
FT                   HWVESFQKAREEGSGSGTWRGRWRRR (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_054883"
FT   VAR_SEQ         104..144
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_035428"
FT   VAR_SEQ         529..572
FT                   /note="Missing (in isoform Beta)"
FT                   /evidence="ECO:0000303|PubMed:9931472"
FT                   /id="VSP_002428"
FT   STRAND          4..8
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          10..18
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          20..25
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          35..41
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          46..49
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           50..54
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   TURN            55..59
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           60..62
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          63..66
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           68..70
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           78..84
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          88..93
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          97..104
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          106..113
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           114..133
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          139..144
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           150..163
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          166..172
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           173..184
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          196..203
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          208..216
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          219..228
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           233..252
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           256..258
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           260..276
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   TURN            277..279
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          284..292
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          295..301
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           303..309
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           311..316
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           318..328
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           332..334
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   STRAND          337..343
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           344..346
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           348..358
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   TURN            368..370
FT                   /evidence="ECO:0007744|PDB:6GFA"
FT   HELIX           371..379
FT                   /evidence="ECO:0007744|PDB:6GFA"
SQ   SEQUENCE   858 AA;  96865 MW;  D0E757970E340B56 CRC64;
     MSVVGLDVGS QSCYIAVARA GGIETIANEF SDRCTPSVIS FGSKNRTIGV AAKNQQITHA
     NNTVSNFKRF HGRAFNDPFI QKEKENLSYD LVPLKNGGVG IKVMYMGEEH LFSVEQITAM
     LLTKLKETAE NSLKKPVTDC VISVPSFFTD AERRSVLDAA QIVGLNCLRL MNDMTAVALN
     YGIYKQDLPS LDEKPRIVVF VDMGHSAFQV SACAFNKGKL KVLGTAFDPF LGGKNFDEKL
     VEHFCAEFKT KYKLDAKSKI RALLRLYQEC EKLKKLMSSN STDLPLNIEC FMNDKDVSGK
     MNRSQFEELC AELLQKIEVP LYSLLEQTHL KVEDVSAVEI VGGATRIPAV KERIAKFFGK
     DISTTLNADE AVARGCALQC AILSPAFKVR EFSVTDAVPF PISLIWNHDS EDTEGVHEVF
     SRNHAAPFSK VLTFLRRGPF ELEAFYSDPQ GVPYPEAKIG RFVVQNVSAQ KDGEKSRVKV
     KVRVNTHGIF TISTASMVEK VPTEENEMSS EADMECLNQR PPENPDTDKN VQQDNSEAGT
     QPQVQTDAQQ TSQSPPSPEL TSEENKIPDA DKANEKKVDQ PPEAKKPKIK VVNVELPIEA
     NLVWQLGKDL LNMYIETEGK MIMQDKLEKE RNDAKNAVEE YVYEFRDKLC GPYEKFICEQ
     DHQNFLRLLT ETEDWLYEEG EDQAKQAYVD KLEELMKIGT PVKVRFQEAE ERPKMFEELG
     QRLQHYAKIA ADFRNKDEKY NHIDESEMKK VEKSVNEVME WMNNVMNAQA KKSLDQDPVV
     RAQEIKTKIK ELNNTCEPVV TQPKPKIESP KLERTPNGPN IDKKEEDLED KNNFGAEPPH
     QNGECYPNEK NSVNMDLD
//
